WELGENE BIOTECH CO LTD - stock earnings
6661.TWO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -4.9 million TWD | 49.1 million TWD |
| 2022Q3 | 4.7 million TWD | 72.2 million TWD |
| 2022Q2 | 12.5 million TWD | 105.5 million TWD |
| 2022Q1 | -5.1 million TWD | 72.0 million TWD |
6661.TWO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 13.7 million TWD | 312.7 million TWD |
| 2020 | 29.8 million TWD | 398.1 million TWD |
| 2019 | 30.9 million TWD | 417.5 million TWD |
6661.TWO
Price: NT$22.20
52 week price:
Payout Ratio: -164.91%
Payout Ratio Range:
Earnings Per Share: -0.14 TWD
P/E Ratio: 171.54
Exchange: TWO
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 520.8 million
Average Dividend Frequency: 1
Years Paying Dividends: 6
DGR3: -30.00%